saccharomyces boulardii and Improved FEV1/FVC Ratio

• A Randomized, Controlled Study Evaluating Effects of Saccharomyces boulardii in Adult Patients with Asthma.

  • 2025-04-14
  • RCT · n = 25
  • Drug research 75(05)
  • • Kavosh Ansari Dezfouli
    • Mahboubeh Darban
    • Maral Hemmati
    • Mazyar Zahir
    • Mojtaba Soltani Kermanshahi
    • Anna Abdolshahi
    • Hani Sadr
    • Bahador Bagheri

  • PubMed: 40228543
  • DOI: 10.1055/a-2564-2569

  6 Insights on

  • Improved FEV1/FVC Ratio

  • High evidence
  • Clinical

  Although the changes in FEV1, FVC, FEV1/FVC, and FEF 25-75% were comparable between the study groups, the differences were not statistically significant (p > 0.05).

  Effect

  Neutral

  Effect size

  Small

  Significant

  No